{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:51:27Z","timestamp":1787637087749,"version":"build-2736575974"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Only 10% of new lymphoma diagnoses in the USA occur in children\u2009&lt;\u200915\u00a0years. Although the same diagnostic criteria apply to both adult and pediatric lymphomas, there are important differences in some lymphoma subtypes. These differences are recognized by the World Health Organization (WHO) with the recent 2022 classification of pediatric tumors including pediatric hematopoietic tumors. Here, we review the WHO classification scheme for pediatric lymphomas and summarize the diagnostic criteria, recent genetic findings, and differences from their adult counterparts for some subtypes including those yet to be included as a definitive subtype. In general, there are differences in relatively frequency, genetic mutation, and prognosis with the pediatric counterpart often having better prognosis. Emerging B-cell lymphomas with recurrent gene alterations such as\n                    <jats:italic>IRF4<\/jats:italic>\n                    rearrangement and 11q gain\/loss chromosomal alterations will be reviewed. The overlapping pathological, clinical, and molecular features between pediatric-type follicular lymphoma (PTFL) and pediatric nodal marginal zone lymphoma (PNMZL) suggesting one disease with broad morphological spectrum will be discussed. The pathogenetic role of EBV in subclassifying Burkitt lymphoma is highlighted. The revised classification of the EBV-positive lymphoproliferative disorders in children is discussed. This review will focus on novel findings, areas of special interest, and diagnostic challenges in pediatric lymphomas.\n                  <\/jats:p>","DOI":"10.1007\/s00428-024-03980-9","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T22:53:13Z","timestamp":1734735193000},"page":"81-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pediatric lymphomas: overview and diagnostic challenges"],"prefix":"10.1007","volume":"486","author":[{"given":"John Kim","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-5365","authenticated-orcid":false,"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"3980_CR1","unstructured":"Leukemia & Lymphoma Society (2023) https:\/\/www.lls.org\/booklet\/facts-updated-data-blood-cancers. Accessed 30 Jun 2024"},{"key":"3980_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511781292","volume-title":"Diagnostic pediatric hematopathology","author":"MA Proytcheva","year":"2011","unstructured":"Proytcheva MA (2011) Diagnostic pediatric hematopathology. Cambridge University Press, Cambridge, New York"},{"key":"3980_CR3","doi-asserted-by":"publisher","first-page":"104672","DOI":"10.1016\/j.ejmg.2022.104672","volume":"66","author":"M Simonin","year":"2023","unstructured":"Simonin M, Jardin F, Leblanc T, Latour S, Landman Parker J (2023) An update on molecular features and therapeutic perspectives of pediatric classical Hodgkin lymphoma. What the clinician needs to know? Eur J Med Genet 66:104672. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104672","journal-title":"Eur J Med Genet"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00428-023-03493-x","volume":"482","author":"J Lee","year":"2023","unstructured":"Lee J, Han JH, Lee CH, Park HS, Min SK, Lee H, Cho U, Yoon SE, Kim SJ, Kim WS, Cho J (2023) Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Virchows Arch 482:849\u2013858. https:\/\/doi.org\/10.1007\/s00428-023-03493-x","journal-title":"Virchows Arch"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"e45937","DOI":"10.7759\/cureus.45937","volume":"15","author":"TI Britto","year":"2023","unstructured":"Britto TI, Fattah SA, Rahman MAU, Chowdhury MAU (2023) A systematic review on childhood non-Hodgkin lymphoma: an overlooked phenomenon in the health and research sector of Bangladesh. Cureus 15:e45937. https:\/\/doi.org\/10.7759\/cureus.45937","journal-title":"Cureus"},{"key":"3980_CR6","doi-asserted-by":"publisher","first-page":"e28416","DOI":"10.1002\/pbc.28416","volume":"67","author":"A Attarbaschi","year":"2020","unstructured":"Attarbaschi A, Abla O, Arias Padilla L, Beishuizen A, Burke GAA, Brugieres L, Bruneau J, Burkhardt B, d\u2019Amore ESG, Klapper W, Kontny U, Pillon M, Taj M, Turner SD, Uyttebroeck A, Woessmann W, Mellgren K (2020) Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. Pediatr Blood Cancer 67:e28416. https:\/\/doi.org\/10.1002\/pbc.28416","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2022016534","volume":"141","author":"N Thomas","year":"2023","unstructured":"Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD (2023) Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood 141:904\u2013916. https:\/\/doi.org\/10.1182\/blood.2022016534","journal-title":"Blood"},{"key":"3980_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/15513815.2022.2120786","volume":"42","author":"TDA Phan","year":"2023","unstructured":"Phan TDA, Duong TT, Thi Nhu Pham D, Hoang Dang M, Thanh Ly T, Thi Tuyet Ngo H, Ngo DQ, Trinh NDT, Le Ly U, Anh Thai T, Thi Ngoc Hua H, Thi Phuong Doan T (2023) A Multicenter study of clinicopathology and immunohistochemical distinction between adult and pediatric large B-cell lymphoma. Fetal Pediatr Pathol 42:355\u2013366. https:\/\/doi.org\/10.1080\/15513815.2022.2120786","journal-title":"Fetal Pediatr Pathol"},{"issue":"Suppl 6","key":"3980_CR9","doi-asserted-by":"publisher","first-page":"e30565","DOI":"10.1002\/pbc.30565","volume":"70","author":"NK El-Mallawany","year":"2023","unstructured":"El-Mallawany NK, Alexander S, Fluchel M, Hayashi RJ, Lowe EJ, Giulino-Roth L, Wistinghausen B, Hermiston M, Allen CE, Committee CN (2023) Children\u2019s Oncology Group\u2019s 2023 blueprint for research: non-Hodgkin lymphoma. Pediatr Blood Cancer 70(Suppl 6):e30565. https:\/\/doi.org\/10.1002\/pbc.30565","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 6","key":"3980_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30580","volume":"70","author":"SM Castellino","year":"2023","unstructured":"Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM, Committee COGHL (2023) Children\u2019s Oncology Group\u2019s 2023 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer 70(Suppl 6):e30580. https:\/\/doi.org\/10.1002\/pbc.30580","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/bjh.17639","volume":"194","author":"K Ohki","year":"2021","unstructured":"Ohki K, Kiyokawa N, Watanabe S, Iwafuchi H, Nakazawa A, Ishiwata K, Ogata-Kawata H, Nakabayashi K, Okamura K, Tanaka F, Fukano R, Hata K, Mori T, Moriya Saito A, Hayashi Y, Taga T, Sekimizu M, Japan Children\u2019s Cancer Study G (2021) Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children\u2019s Cancer Group (JCCG). Br J Haematol 194:718\u2013729. https:\/\/doi.org\/10.1111\/bjh.17639","journal-title":"Br J Haematol"},{"key":"3980_CR12","doi-asserted-by":"publisher","first-page":"e29285","DOI":"10.1002\/pbc.29285","volume":"68","author":"RKH Au-Yeung","year":"2021","unstructured":"Au-Yeung RKH, Richter J, Iaccarino I, Abramov D, Bacon CM, Balague O, d\u2019Amore ESG, Simonitsch-Klupp I, Hebeda K, Nakazawa A, Oschlies I, Kontny U, Woessmann W, Burkhardt B, Klapper W (2021) Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. Pediatr Blood Cancer 68:e29285. https:\/\/doi.org\/10.1002\/pbc.29285","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR13","unstructured":"Alaggio R, Hasle, H (2022) Haematolymphoid disorders. In: WHO classification of tumours editorial board. Paediatric tumours [Internet]. WHO classification of tumours series. https:\/\/tumourclassification.iarc.who.int\/chapters\/44. Accessed 6\/30\/2024 2024"},{"key":"3980_CR14","unstructured":"(2024) WHO classification of tumours editorial board. Haematolymphoid tumours [Internet]. WHO classification of tumours series. https:\/\/tumourclassification.iarc.who.int\/chapters\/63. Accessed 6\/30\/2024 2024"},{"key":"3980_CR15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d\u2019Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140:1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"3980_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","volume":"2","author":"S Jeha","year":"2021","unstructured":"Jeha S, Choi J, Roberts KG, Pei D, Coustan-Smith E, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Karol SE, Qu C, Brady SW, Gu Z, Yang JJ, Cheng C, Downing JR, Evans WE, Relling MV, Campana D, Mullighan CG, Pui CH (2021) Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. Blood Cancer Discov 2:326\u2013337. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0229","journal-title":"Blood Cancer Discov"},{"key":"3980_CR17","doi-asserted-by":"publisher","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","volume":"115","author":"JF Li","year":"2018","unstructured":"Li JF, Dai YT, Lilljebjorn H, Shen SH, Cui BW, Bai L, Liu YF, Qian MX, Kubota Y, Kiyoi H, Matsumura I, Miyazaki Y, Olsson L, Tan AM, Ariffin H, Chen J, Takita J, Yasuda T, Mano H, Johansson B, Yang JJ, Yeoh AE, Hayakawa F, Chen Z, Pui CH, Fioretos T, Chen SJ, Huang JY (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A 115:E11711\u2013E11720. https:\/\/doi.org\/10.1073\/pnas.1814397115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3980_CR18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, Wei L, Arunachalam S, Hagiwara K, Liu Y, Flasch DA, Liu Y, Parker M, Chen X, Elsayed AH, Pathak O, Li Y, Fan Y, Michael JR, Rusch M, Wilkinson MR, Foy S, Hedges DJ, Newman S, Zhou X, Wang J, Reilly C, Sioson E, Rice SV, Pastor Loyola V, Wu G, Rampersaud E, Reshmi SC, Gastier-Foster J, Guidry Auvil JM, Gesuwan P, Smith MA, Winick N, Carroll AJ, Heerema NA, Harvey RC, Willman CL, Larsen E, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Winter SS, Burke MJ, Salzer W, Dunsmore KP, Angiolillo AL, Crews KR, Downing JR, Jeha S, Pui CH, Evans WE, Yang JJ, Relling MV, Gerhard DS, Loh ML, Hunger SP, Zhang J, Mullighan CG (2022) The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet 54:1376\u20131389. https:\/\/doi.org\/10.1038\/s41588-022-01159-z","journal-title":"Nat Genet"},{"key":"3980_CR19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024023938","author":"E Kroeze","year":"2024","unstructured":"Kroeze E, Iaccarino I, Kleisman MM, Mondal M, Beder T, Khouja M, Hoppner MP, Scheijde-Vermeulen MA, Kester LA, Bruggemann M, Baldus CD, Cario G, Bladergroen RS, Garnier N, Attarbaschi A, Verdu-Amoros J, Sutton R, Macintyre EA, Scholten K, Arias Padilla L, Burkhardt B, Beishuizen A, den Boer ML, Kuiper RP, Loeffen JLC, Boer JM, Klapper W (2024) Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2024023938","journal-title":"Blood"},{"key":"3980_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/pbc.24149","volume":"59","author":"AM Termuhlen","year":"2012","unstructured":"Termuhlen AM, Smith LM, Perkins SL, Lones M, Finlay JL, Weinstein H, Gross TG, Abromowitch M (2012) Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children\u2019s Oncology Group trial A5971: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 59:1229\u20131233. https:\/\/doi.org\/10.1002\/pbc.24149","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.6004\/jnccn.2023.7004","volume":"21","author":"CJ Forlenza","year":"2023","unstructured":"Forlenza CJ, Chadburn A, Giulino-Roth L (2023) Primary mediastinal B-cell lymphoma in children and young adults. J Natl Compr Canc Netw 21:323\u2013330. https:\/\/doi.org\/10.6004\/jnccn.2023.7004","journal-title":"J Natl Compr Canc Netw"},{"key":"3980_CR22","doi-asserted-by":"publisher","unstructured":"Huibers M, Abla O, Andres M, Balague O, Beishuizen A, Carraro E, Chiang A, Csoka M, David BA, de Ville de Goyet M, Gilad G, Hori D, Kotecha RS, Kabickova E, Klapper W, Miakova N, Minard-Colin V, Nakazawa A, Pillon M, Rigaud C, Salaverria I, Tolle I, Verdu-Amoros J, von Mersi H, Wossmann W, Burkhardt B, Attarbaschi A (2024) Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm? Blood Adv 8:1509-1514. https:\/\/doi.org\/10.1182\/bloodadvances.2023012109","DOI":"10.1182\/bloodadvances.2023012109"},{"key":"3980_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/bjh.16578","volume":"190","author":"RKH Au-Yeung","year":"2020","unstructured":"Au-Yeung RKH, Arias Padilla L, Zimmermann M, Oschlies I, Siebert R, Woessmann W, Burkhardt B, Klapper W (2020) Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol 190:753\u2013763. https:\/\/doi.org\/10.1111\/bjh.16578","journal-title":"Br J Haematol"},{"key":"3980_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","volume":"25","author":"DM Dorfman","year":"2012","unstructured":"Dorfman DM, Shahsafaei A, Alonso MA (2012) Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers. Mod Pathol 25:1637\u20131643. https:\/\/doi.org\/10.1038\/modpathol.2012.129","journal-title":"Mod Pathol"},{"key":"3980_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","volume":"41","author":"M Gentry","year":"2017","unstructured":"Gentry M, Bodo J, Durkin L, Hsi ED (2017) Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma. Am J Surg Pathol 41:189\u2013194. https:\/\/doi.org\/10.1097\/PAS.0000000000000771","journal-title":"Am J Surg Pathol"},{"key":"3980_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/PAS.0000000000000297","volume":"38","author":"M Shi","year":"2014","unstructured":"Shi M, Roemer MG, Chapuy B, Liao X, Sun H, Pinkus GS, Shipp MA, Freeman GJ, Rodig SJ (2014) Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain. Am J Surg Pathol 38:1715\u20131723. https:\/\/doi.org\/10.1097\/PAS.0000000000000297","journal-title":"Am J Surg Pathol"},{"key":"3980_CR27","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","volume":"13","author":"A Mottok","year":"2015","unstructured":"Mottok A, Woolcock B, Chan FC, Tong KM, Chong L, Farinha P, Telenius A, Chavez E, Ramchandani S, Drake M, Boyle M, Ben-Neriah S, Scott DW, Rimsza LM, Siebert R, Gascoyne RD, Steidl C (2015) Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression. Cell Rep 13:1418\u20131431. https:\/\/doi.org\/10.1016\/j.celrep.2015.10.008","journal-title":"Cell Rep"},{"key":"3980_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjh.14951","volume":"179","author":"L Giulino-Roth","year":"2017","unstructured":"Giulino-Roth L, O\u2019Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B, Casulo C, Smith SM, Godfrey J, Termuhlen A, Oberley MJ, Alexander S, Weitzman S, Appel B, Mizukawa B, Svoboda J, Afify Z, Pauly M, Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard JP (2017) Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol 179:739\u2013747. https:\/\/doi.org\/10.1111\/bjh.14951","journal-title":"Br J Haematol"},{"key":"3980_CR29","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3324\/haematol.2021.278971","volume":"106","author":"F Knorr","year":"2021","unstructured":"Knorr F, Zimmermann M, Attarbaschi A, Kabickova E, Maecker-Kolhoff B, Ruf S, Kuhnle I, Ebinger M, Garthe AK, Simonitsch-Klupp I, Oschlies I, Klapper W, Burkhardt B, Woessmann W (2021) Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma. Haematologica 106:3232\u20133235. https:\/\/doi.org\/10.3324\/haematol.2021.278971","journal-title":"Haematologica"},{"key":"3980_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3324\/haematol.2010.030809","volume":"96","author":"I Oschlies","year":"2011","unstructured":"Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, d\u2019Amore ES, Szczepanowski M, Koch K, Hansmann ML, Stein H, Moller P, Reiter A, Zimmermann M, Rosolen A, Siebert R, Jaffe ES, Klapper W (2011) Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 96:262\u2013268. https:\/\/doi.org\/10.3324\/haematol.2010.030809","journal-title":"Haematologica"},{"key":"3980_CR31","doi-asserted-by":"publisher","unstructured":"Perwein T, Lackner H, Ebetsberger-Dachs G, Beham-Schmid C, Zach K, Tamesberger M, Simonitsch-Klupp I, Luftinger R, Dworzak M, Mann G, Benesch M, Attarbaschi A, Austrian Society of Pediatric H, Oncology, the Austrian Berlin-Frankfurt-Munster Study G (2020) Management of children and adolescents with gray zone lymphoma: a case series. Pediatr Blood Cancer 67:e28206. https:\/\/doi.org\/10.1002\/pbc.28206","DOI":"10.1002\/pbc.28206"},{"key":"3980_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","volume":"1","author":"S Pittaluga","year":"2020","unstructured":"Pittaluga S, Nicolae A, Wright GW, Melani C, Roschewski M, Steinberg S, Huang D, Staudt LM, Jaffe ES, Wilson WH (2020) Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma. Blood Cancer Discov 1:155\u2013161. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0009","journal-title":"Blood Cancer Discov"},{"key":"3980_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood.2020007507","volume":"137","author":"C Sarkozy","year":"2021","unstructured":"Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW, Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A, Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW, Traverse-Glehen A, Steidl C (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765\u20131776. https:\/\/doi.org\/10.1182\/blood.2020007507","journal-title":"Blood"},{"key":"3980_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES (2015) EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863\u2013872. https:\/\/doi.org\/10.1182\/blood-2015-02-630632","journal-title":"Blood"},{"key":"3980_CR35","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","volume":"1","author":"M Pilichowska","year":"2017","unstructured":"Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM (2017) Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv 1:2600\u20132609. https:\/\/doi.org\/10.1182\/bloodadvances.2017009472","journal-title":"Blood Adv"},{"key":"3980_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bjh.14812","volume":"179","author":"M Szczepanowski","year":"2017","unstructured":"Szczepanowski M, Lange J, Kohler CW, Masque-Soler N, Zimmermann M, Aukema SM, Altenbuchinger M, Rehberg T, Mahn F, Siebert R, Spang R, Burkhardt B, Klapper W (2017) Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents. Br J Haematol 179:116\u2013119. https:\/\/doi.org\/10.1111\/bjh.14812","journal-title":"Br J Haematol"},{"key":"3980_CR37","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","volume":"107","author":"I Oschlies","year":"2006","unstructured":"Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker HH, Burkhardt B, Harder L, Siebert R, Reiter A, Parwaresch R (2006) Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood 107:4047\u20134052. https:\/\/doi.org\/10.1182\/blood-2005-10-4213","journal-title":"Blood"},{"key":"3980_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2019002699","volume":"135","author":"JE Ramis-Zaldivar","year":"2020","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Balague O, Celis V, Nadeu F, Salmeron-Villalobos J, Andres M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Sunol M, Barcena C, Garcia-Bragado F, Andion M, Azorin D, Astigarraga I, Sagaseta de Ilurdoz M, Sabado C, Gallego S, Verdu-Amoros J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Paez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, Lopez-Guillermo A, Galera P, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, Campo E, Salaverria I (2020) Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood 135:274\u2013286. https:\/\/doi.org\/10.1182\/blood.2019002699","journal-title":"Blood"},{"key":"3980_CR39","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.humpath.2015.01.011","volume":"46","author":"S Uccini","year":"2015","unstructured":"Uccini S, Al-Jadiry MF, Scarpino S, Ferraro D, Alsaadawi AR, Al-Darraji AF, Moleti ML, Testi AM, Al-Hadad SA, Ruco L (2015) Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Hum Pathol 46:716\u2013724. https:\/\/doi.org\/10.1016\/j.humpath.2015.01.011","journal-title":"Hum Pathol"},{"key":"3980_CR40","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/ijc.28942","volume":"135","author":"M Cohen","year":"2014","unstructured":"Cohen M, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA (2014) Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients. Int J Cancer 135:2816\u20132824. https:\/\/doi.org\/10.1002\/ijc.28942","journal-title":"Int J Cancer"},{"key":"3980_CR41","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/ijc.27845","volume":"132","author":"M Cohen","year":"2013","unstructured":"Cohen M, De Matteo E, Narbaitz M, Carreno FA, Preciado MV, Chabay PA (2013) Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment. Int J Cancer 132:1572\u20131580. https:\/\/doi.org\/10.1002\/ijc.27845","journal-title":"Int J Cancer"},{"key":"3980_CR42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/annonc\/mdu556","volume":"26","author":"JY Hong","year":"2015","unstructured":"Hong JY, Yoon DH, Suh C, Huh J, Do IG, Sohn I, Jo J, Jung SH, Hong ME, Yoon H, Ko YH, Kim SJ, Kim WS (2015) EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity? Ann Oncol 26:548\u2013555. https:\/\/doi.org\/10.1093\/annonc\/mdu556","journal-title":"Ann Oncol"},{"key":"3980_CR43","doi-asserted-by":"publisher","unstructured":"Quintanilla-Martinez L, Laurent C, Soma L, Ng SB, Climent F, Ondrejka SL, Zamo A, Wotherspoon A, de Leval L, Dirnhofer S, Leoncini L (2023) Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop Virchows Arch 483:281\u2013298. https:\/\/doi.org\/10.1007\/s00428-023-03590-x","DOI":"10.1007\/s00428-023-03590-x"},{"key":"3980_CR44","volume-title":"WHO classfication of tumours of haematopoietic and lymphoid tissues","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (eds) (2017) WHO classfication of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, Pages"},{"key":"3980_CR45","doi-asserted-by":"publisher","first-page":"e27770","DOI":"10.1002\/pbc.27770","volume":"66","author":"KM Chisholm","year":"2019","unstructured":"Chisholm KM, Mohlman J, Liew M, Termuhlen A, Cairo MS, Gross TG, Perkins SL, Miles RR (2019) IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children\u2019s Oncology Group trials. Pediatr Blood Cancer 66:e27770. https:\/\/doi.org\/10.1002\/pbc.27770","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR46","doi-asserted-by":"publisher","unstructured":"Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, Burkhardt B, Trautmann H, Gesk S, Andrusiewicz M, Berger H, Fey M, Harder L, Hasenclever D, Hummel M, Loeffler M, Mahn F, Martin-Guerrero I, Pellissery S, Pott C, Pfreundschuh M, Reiter A, Richter J, Rosolowski M, Schwaenen C, Stein H, Trumper L, Wessendorf S, Spang R, Kuppers R, Klapper W, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche K, German High-Grade Lymphoma Study G, Berlin-Frankfurt-Munster NHLtg (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118:139-147. https:\/\/doi.org\/10.1182\/blood-2011-01-330795","DOI":"10.1182\/blood-2011-01-330795"},{"key":"3980_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","volume":"131","author":"HE Berg","year":"2023","unstructured":"Berg HE, Peterson JF, Lee HE, McPhail ED (2023) Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients. Hum Pathol 131:108\u2013115. https:\/\/doi.org\/10.1016\/j.humpath.2022.10.011","journal-title":"Hum Pathol"},{"key":"3980_CR48","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1182\/bloodadvances.2022009456","volume":"7","author":"I Salaverria","year":"2023","unstructured":"Salaverria I, Weigert O, Quintanilla-Martinez L (2023) The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas. Blood Adv 7:5258\u20135271. https:\/\/doi.org\/10.1182\/bloodadvances.2022009456","journal-title":"Blood Adv"},{"key":"3980_CR49","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1002\/cam4.5828","volume":"12","author":"XN Jiang","year":"2023","unstructured":"Jiang XN, Yu F, Xue T, Xia QX, Bai QM, Yu BH, Shui RH, Zhou XY, Zhu XZ, Cao JN, Hong XN, Li XQ (2023) IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma. Cancer Med 12:10684\u201310693. https:\/\/doi.org\/10.1002\/cam4.5828","journal-title":"Cancer Med"},{"key":"3980_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/pbc.26236","volume":"64","author":"L Chen","year":"2017","unstructured":"Chen L, Al-Kzayer LF, Liu T, Kobayashi N, Nakazawa Y, Koike K (2017) IFR4\/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10. Pediatr Blood Cancer 64:311\u2013314. https:\/\/doi.org\/10.1002\/pbc.26236","journal-title":"Pediatr Blood Cancer"},{"key":"3980_CR51","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/01.pas.0000170350.85798.f4","volume":"29","author":"JA Schrager","year":"2005","unstructured":"Schrager JA, Pittaluga S, Raffeld M, Jaffe ES (2005) Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. Am J Surg Pathol 29:1115\u20131116","journal-title":"Am J Surg Pathol"},{"key":"3980_CR52","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/his.14391","volume":"80","author":"M Granai","year":"2022","unstructured":"Granai M, Lazzi S, Mancini V, Akarca A, Santi R, Vergoni F, Sorrentino E, Guazzo R, Mundo L, Cevenini G, Tripodo C, Di Stefano G, Puccini B, Ponzoni M, Sabattini E, Agostinelli C, Bassullu N, Tecimer T, Demiroz AS, Mnango L, Dirnhofer S, Quintanilla-Martinez L, Marafioti T, Fend F, Leoncini L (2022) Burkitt lymphoma with a granulomatous reaction: an M1\/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression. Histopathology 80:430\u2013442. https:\/\/doi.org\/10.1111\/his.14391","journal-title":"Histopathology"},{"key":"3980_CR53","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","volume":"132","author":"R Wagener","year":"2018","unstructured":"Wagener R, Lopez C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, Toprak UH, Seufert J, Altmuller J, Thiele H, Schneider C, Kolarova J, Park J, Hubschmann D, Murga Penas EM, Drexler HG, Attarbaschi A, Hovland R, Kjeldsen E, Kneba M, Kontny U, de Leval L, Nurnberg P, Oschlies I, Oscier D, Schlegelberger B, Stilgenbauer S, Wossmann W, Schlesner M, Burkhardt B, Klapper W, Jaffe ES, Kuppers R, Siebert R (2018) IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. Blood 132:2280\u20132285. https:\/\/doi.org\/10.1182\/blood-2018-03-842088","journal-title":"Blood"},{"key":"3980_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116\u2013120. https:\/\/doi.org\/10.1038\/nature11378","journal-title":"Nature"},{"key":"3980_CR55","doi-asserted-by":"publisher","unstructured":"Lopez C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, Hubschmann D, Wagener R, Toprak UH, Raimondi F, Kreuz M, Waszak SM, Huang Z, Sieverling L, Paramasivam N, Seufert J, Sungalee S, Russell RB, Bausinger J, Kretzmer H, Ammerpohl O, Bergmann AK, Binder H, Borkhardt A, Brors B, Claviez A, Doose G, Feuerbach L, Haake A, Hansmann ML, Hoell J, Hummel M, Korbel JO, Lawerenz C, Lenze D, Radlwimmer B, Richter J, Rosenstiel P, Rosenwald A, Schilhabel MB, Stein H, Stilgenbauer S, Stadler PF, Szczepanowski M, Weniger MA, Zapatka M, Eils R, Lichter P, Loeffler M, Moller P, Trumper L, Klapper W, Consortium IM-S, Hoffmann S, Kuppers R, Burkhardt B, Schlesner M, Siebert R (2019) Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun 10:1459. https:\/\/doi.org\/10.1038\/s41467-019-08578-3","DOI":"10.1038\/s41467-019-08578-3"},{"key":"3980_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM (2019) Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133:1313\u20131324. https:\/\/doi.org\/10.1182\/blood-2018-09-871418","journal-title":"Blood"},{"key":"3980_CR57","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L de Leval","year":"2022","unstructured":"de Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies A, Dogan A, Fitzgibbon J, Horwitz SM, Melnick AM, Morice WG, Morin RD, Nadel B, Pileri SA, Rosenquist R, Rossi D, Salaverria I, Steidl C, Treon SP, Zelenetz AD, Advani RH, Allen CE, Ansell SM, Chan WC, Cook JR, Cook LB, d\u2019Amore F, Dirnhofer S, Dreyling M, Dunleavy K, Feldman AL, Fend F, Gaulard P, Ghia P, Gribben JG, Hermine O, Hodson DJ, Hsi ED, Inghirami G, Jaffe ES, Karube K, Kataoka K, Klapper W, Kim WS, King RL, Ko YH, LaCasce AS, Lenz G, Martin-Subero JI, Piris MA, Pittaluga S, Pasqualucci L, Quintanilla-Martinez L, Rodig SJ, Rosenwald A, Salles GA, San-Miguel J, Savage KJ, Sehn LH, Semenzato G, Staudt LM, Swerdlow SH, Tam CS, Trotman J, Vose JM, Weigert O, Wilson WH, Winter JN, Wu CJ, Zinzani PL, Zucca E, Bagg A, Scott DW (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140:2193\u20132227. https:\/\/doi.org\/10.1182\/blood.2022015854","journal-title":"Blood"},{"key":"3980_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1182\/blood.2023023242","volume":"144","author":"M Sureda-Gomez","year":"2024","unstructured":"Sureda-Gomez M, Iaccarino I, De Bolos A, Meyer M, Balsas P, Richter J, Rodriguez ML, Lopez C, Carreras-Caballe M, Glaser S, Nadeu F, Jares P, Clot G, Siciliano MC, Bellan C, Tornambe S, Boccacci R, Leoncini L, Campo E, Siebert R, Amador V, Klapper W (2024) SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features. Blood 144:187\u2013200. https:\/\/doi.org\/10.1182\/blood.2023023242","journal-title":"Blood"},{"key":"3980_CR59","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","volume":"133","author":"R Wagener","year":"2019","unstructured":"Wagener R, Seufert J, Raimondi F, Bens S, Kleinheinz K, Nagel I, Altmuller J, Thiele H, Hubschmann D, Kohler CW, Nurnberg P, Au-Yeung R, Burkhardt B, Horn H, Leoncini L, Jaffe ES, Ott G, Rymkiewicz G, Schlesner M, Russell RB, Klapper W, Siebert R (2019) The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood 133:962\u2013966. https:\/\/doi.org\/10.1182\/blood-2018-07-864025","journal-title":"Blood"},{"key":"3980_CR60","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","volume":"104","author":"B Gonzalez-Farre","year":"2019","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balague O, Celis V, Verdu-Amoros J, Nadeu F, Sabado C, Ferrandez A, Garrido M, Garcia-Bragado F, de la Maya MD, Vagace JM, Panizo CM, Astigarraga I, Andres M, Jaffe ES, Campo E, Salaverria I (2019) Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica 104:1822\u20131829. https:\/\/doi.org\/10.3324\/haematol.2018.207928","journal-title":"Haematologica"},{"key":"3980_CR61","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/modpathol.2017.186","volume":"31","author":"G Rymkiewicz","year":"2018","unstructured":"Rymkiewicz G, Grygalewicz B, Chechlinska M, Blachnio K, Bystydzienski Z, Romejko-Jarosinska J, Woroniecka R, Zajdel M, Domanska-Czyz K, Martin-Garcia D, Nadeu F, Swoboda P, Rygier J, Pienkowska-Grela B, Siwicki JK, Prochorec-Sobieszek M, Salaverria I, Siebert R, Walewski J (2018) A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Mod Pathol 31:732\u2013743. https:\/\/doi.org\/10.1038\/modpathol.2017.186","journal-title":"Mod Pathol"},{"key":"3980_CR62","doi-asserted-by":"publisher","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Kuppers R, Lefebvre C, Lisfeld J, Loffler M, Macleod RA, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trumper L, Vater I, Wessendorf S, Klapper W, Siebert R, Molecular Mechanisms in Malignant Lymphoma Network P, Berlin-Frankfurt-Munster Non-Hodgkin Lymphoma G (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123:1187-1198. https:\/\/doi.org\/10.1182\/blood-2013-06-507996","DOI":"10.1182\/blood-2013-06-507996"},{"key":"3980_CR63","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","volume":"6","author":"J Salmeron-Villalobos","year":"2022","unstructured":"Salmeron-Villalobos J, Egan C, Borgmann V, Muller I, Gonzalez-Farre B, Ramis-Zaldivar JE, Nann D, Balague O, Lopez-Guerra M, Colomer D, Oschlies I, Klapper W, Glaser S, Ko YH, Bonzheim I, Siebert R, Fend F, Pittaluga S, Campo E, Salaverria I, Jaffe ES, Quintanilla-Martinez L (2022) A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. Blood Adv 6:4661\u20134674. https:\/\/doi.org\/10.1182\/bloodadvances.2022007322","journal-title":"Blood Adv"},{"key":"3980_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","volume":"468","author":"L Quintanilla-Martinez","year":"2016","unstructured":"Quintanilla-Martinez L, Sander B, Chan JK, Xerri L, Ott G, Campo E, Swerdlow SH (2016) Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch 468:141\u2013157. https:\/\/doi.org\/10.1007\/s00428-015-1855-z","journal-title":"Virchows Arch"},{"key":"3980_CR65","doi-asserted-by":"publisher","first-page":"e22023","DOI":"10.7759\/cureus.22023","volume":"14","author":"AF Alnaim","year":"2022","unstructured":"Alnaim AF, Alhawsawi A, AlSomali A, Jannadi R, Alsolami SM, Alotaibi HA (2022) Conjunctival pediatric-type follicular lymphoma in a young male: a case report and literature review. Cureus 14:e22023. https:\/\/doi.org\/10.7759\/cureus.22023","journal-title":"Cureus"},{"key":"3980_CR66","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","volume":"98","author":"I Martin-Guerrero","year":"2013","unstructured":"Martin-Guerrero I, Salaverria I, Burkhardt B, Szczepanowski M, Baudis M, Bens S, de Leval L, Garcia-Orad A, Horn H, Lisfeld J, Pellissery S, Klapper W, Oschlies I, Siebert R (2013) Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. Haematologica 98:1237\u20131241. https:\/\/doi.org\/10.3324\/haematol.2012.073916","journal-title":"Haematologica"},{"key":"3980_CR67","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","volume":"128","author":"J Schmidt","year":"2016","unstructured":"Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balague O, Mozos A, Cabecadas J, van der Walt J, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldivar JE, Clot G, Barcena C, Perez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L (2016) Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. Blood 128:1101\u20131111. https:\/\/doi.org\/10.1182\/blood-2016-03-703819","journal-title":"Blood"},{"key":"3980_CR68","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","volume":"128","author":"A Louissaint Jr","year":"2016","unstructured":"Louissaint A Jr, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, Roth CG, Paxton CN, Kim S, Namgyal C, Morin R, Morgan EA, Neuberg DS, South ST, Harris MH, Hasserjian RP, Hochberg EP, Garraway LA, Harris NL, Weinstock DM (2016) Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood 128:1093\u20131100. https:\/\/doi.org\/10.1182\/blood-2015-12-682591","journal-title":"Blood"},{"key":"3980_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","volume":"130","author":"J Schmidt","year":"2017","unstructured":"Schmidt J, Ramis-Zaldivar JE, Nadeu F, Gonzalez-Farre B, Navarro A, Egan C, Montes-Mojarro IA, Marafioti T, Cabecadas J, van der Walt J, Dojcinov S, Rosenwald A, Ott G, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L (2017) Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood 130:323\u2013327. https:\/\/doi.org\/10.1182\/blood-2017-03-776278","journal-title":"Blood"},{"key":"3980_CR70","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","volume":"29","author":"MG Ozawa","year":"2016","unstructured":"Ozawa MG, Bhaduri A, Chisholm KM, Baker SA, Ma L, Zehnder JL, Luna-Fineman S, Link MP, Merker JD, Arber DA, Ohgami RS (2016) A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Mod Pathol 29:1212\u20131220. https:\/\/doi.org\/10.1038\/modpathol.2016.102","journal-title":"Mod Pathol"},{"key":"3980_CR71","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/bjh.15194","volume":"184","author":"C Sorge","year":"2019","unstructured":"Sorge C, Costa LJ, Taub JW, M SC, Xavier AC, (2019) Incidence and outcomes of rare paediatric non-hodgkin lymphomas. Br J Haematol 184:864\u2013867. https:\/\/doi.org\/10.1111\/bjh.15194","journal-title":"Br J Haematol"},{"key":"3980_CR72","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1182\/bloodadvances.2021004334","volume":"5","author":"X Xu","year":"2021","unstructured":"Xu X, Paxton CN, Hayashi RJ, Dunsmore KP, Winter SS, Hunger SP, Winick NJ, Carroll WL, Loh ML, Devidas M, Gross TG, Bollard CM, Perkins SL, Miles RR (2021) Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Blood Adv 5:2890\u20132900. https:\/\/doi.org\/10.1182\/bloodadvances.2021004334","journal-title":"Blood Adv"},{"key":"3980_CR73","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41379-022-01085-9","volume":"35","author":"C Bontoux","year":"2022","unstructured":"Bontoux C, Simonin M, Garnier N, Lhermitte L, Touzart A, Andrieu G, Bruneau J, Lengline E, Plesa A, Boissel N, Baruchel A, Bertrand Y, Molina TJ, Macintyre E, Asnafi V (2022) Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia. Mod Pathol 35:1227\u20131235. https:\/\/doi.org\/10.1038\/s41379-022-01085-9","journal-title":"Mod Pathol"},{"key":"3980_CR74","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.13216","volume":"168","author":"U Kontny","year":"2015","unstructured":"Kontny U, Oschlies I, Woessmann W, Burkhardt B, Lisfeld J, Salzburg J, Janda A, Attarbaschi A, Niggli F, Zimmermann M, Reiter A, Klapper W (2015) Non-anaplastic peripheral T-cell lymphoma in children and adolescents\u2013a retrospective analysis of the NHL-BFM study group. Br J Haematol 168:835\u2013844. https:\/\/doi.org\/10.1111\/bjh.13216","journal-title":"Br J Haematol"},{"key":"3980_CR75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","volume":"41","author":"A Nicolae","year":"2017","unstructured":"Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES (2017) EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features. Am J Surg Pathol 41:67\u201374. https:\/\/doi.org\/10.1097\/PAS.0000000000000735","journal-title":"Am J Surg Pathol"},{"key":"3980_CR76","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.trsl.2014.01.010","volume":"163","author":"C Li","year":"2014","unstructured":"Li C, Tian Y, Wang J, Zhu L, Huang L, Wang N, Xu D, Cao Y, Li J, Zhou J (2014) Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia. Transl Res 163:565\u2013577. https:\/\/doi.org\/10.1016\/j.trsl.2014.01.010","journal-title":"Transl Res"},{"key":"3980_CR77","doi-asserted-by":"publisher","first-page":"e25634","DOI":"10.7759\/cureus.25634","volume":"14","author":"UM Donato Jr","year":"2022","unstructured":"Donato UM Jr, Shoeleh C, Galligan A (2022) A case report on aggressive natural killer cell leukemia in a pediatric patient. Cureus 14:e25634. https:\/\/doi.org\/10.7759\/cureus.25634","journal-title":"Cureus"},{"key":"3980_CR78","doi-asserted-by":"publisher","first-page":"829927","DOI":"10.3389\/fped.2022.829927","volume":"10","author":"R Yang","year":"2022","unstructured":"Yang R, Ai Y, Liu C, Lu X (2022) Aggressive natural killer cell leukemia in an adolescent patient: a case report and literature review. Front Pediatr 10:829927. https:\/\/doi.org\/10.3389\/fped.2022.829927","journal-title":"Front Pediatr"},{"key":"3980_CR79","doi-asserted-by":"publisher","unstructured":"Mellgren K, Attarbaschi A, Abla O, Alexander S, Bomken S, Bubanska E, Chiang A, Csoka M, Fedorova A, Kabickova E, Kapuscinska-Kemblowska L, Kobayashi R, Krenova Z, Meyer-Wentrup F, Miakova N, Pillon M, Plat G, Uyttebroeck A, Williams D, Wrobel G, Kontny U, European Intergroup for Childhood Non-Hodgkin L, the international Berlin-Frankfurt-Munster G (2016) Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases. Ann Hematol 95:1295-1305. https:\/\/doi.org\/10.1007\/s00277-016-2722-y","DOI":"10.1007\/s00277-016-2722-y"},{"key":"3980_CR80","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/bjd.13440","volume":"172","author":"I Oschlies","year":"2015","unstructured":"Oschlies I, Simonitsch-Klupp I, Maldyk J, Konovalov D, Abramov D, Myakova N, Lisfeld J, Attarbaschi A, Kontny U, Woessmann W, Klapper W (2015) Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome. Br J Dermatol 172:793\u2013797. https:\/\/doi.org\/10.1111\/bjd.13440","journal-title":"Br J Dermatol"},{"key":"3980_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5021\/ad.2011.23.3.329","volume":"23","author":"DW Lee","year":"2011","unstructured":"Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, Choi JH, Moon KC (2011) Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 Korean patients. Ann Dermatol 23:329\u2013337. https:\/\/doi.org\/10.5021\/ad.2011.23.3.329","journal-title":"Ann Dermatol"},{"key":"3980_CR82","doi-asserted-by":"publisher","unstructured":"Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Canninga-van Dijk MR, Carlotti A, Geerts ML, Hahtola S, Hummel M, Jeskanen L, Kempf W, Massone C, Ortiz-Romero PL, Paulli M, Petrella T, Ranki A, Peralto JL, Robson A, Senff NJ, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ, Group ECL (2008) Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 111:838-845. https:\/\/doi.org\/10.1182\/blood-2007-04-087288","DOI":"10.1182\/blood-2007-04-087288"},{"key":"3980_CR83","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","volume":"50","author":"T Gayden","year":"2018","unstructured":"Gayden T, Sepulveda FE, Khuong-Quang DA, Pratt J, Valera ET, Garrigue A, Kelso S, Sicheri F, Mikael LG, Hamel N, Bajic A, Dali R, Deshmukh S, Dervovic D, Schramek D, Guerin F, Taipale M, Nikbakht H, Majewski J, Moshous D, Charlebois J, Abish S, Bole-Feysot C, Nitschke P, Bader-Meunier B, Mitchell D, Thieblemont C, Battistella M, Gravel S, Nguyen VH, Conyers R, Diana JS, McCormack C, Prince HM, Besnard M, Blanche S, Ekert PG, Fraitag S, Foulkes WD, Fischer A, Neven B, Michonneau D, de Saint BG, Jabado N (2018) Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet 50:1650\u20131657. https:\/\/doi.org\/10.1038\/s41588-018-0251-4","journal-title":"Nat Genet"},{"key":"3980_CR84","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1182\/blood.2019003811","volume":"135","author":"G Sonigo","year":"2020","unstructured":"Sonigo G, Battistella M, Beylot-Barry M, Ingen-Housz-Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socie G, Brice P, Boccara O, Bodemer C, Adamski H, D\u2019Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marcais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahe A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Herve G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Blechet C, Kerdraon R, Lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guerin F, Sepulveda FE, Bagot M, de Saint BG, Michonneau D, de Masson A (2020) HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. Blood 135:1058\u20131061. https:\/\/doi.org\/10.1182\/blood.2019003811","journal-title":"Blood"},{"key":"3980_CR85","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","volume":"79","author":"I Lopez-Lerma","year":"2018","unstructured":"Lopez-Lerma I, Penate Y, Gallardo F, Marti RM, Mitxelena J, Bielsa I, Velasco-Tamariz V, Yanguas-Bayona JI, Sanchez-Sambucety P, Garcia-Patos V, Ortiz-Romero PL, Pujol RM, Estrach T (2018) Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients. J Am Acad Dermatol 79:892\u2013898. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.1243","journal-title":"J Am Acad Dermatol"},{"key":"3980_CR86","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2340\/00015555-2543","volume":"97","author":"D Michonneau","year":"2017","unstructured":"Michonneau D, Petrella T, Ortonne N, Ingen-Housz-Oro S, Franck N, Barete S, Battistella M, Beylot-Barry M, Vergier B, Maynadie M, Bodemer C, Hermine O, Bagot M, Brousse N, Fraitag S (2017) Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy. Acta Derm Venereol 97:358\u2013364. https:\/\/doi.org\/10.2340\/00015555-2543","journal-title":"Acta Derm Venereol"},{"key":"3980_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/his.12251","volume":"64","author":"AD Attygalle","year":"2014","unstructured":"Attygalle AD, Cabecadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH, Said J, Klapper W (2014) Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology 64:171\u2013199. https:\/\/doi.org\/10.1111\/his.12251","journal-title":"Histopathology"},{"key":"3980_CR88","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1182\/blood.2019004118","volume":"136","author":"B Pro","year":"2020","unstructured":"Pro B, Allen P, Behdad A (2020) Hepatosplenic T-cell lymphoma: a rare but challenging entity. Blood 136:2018\u20132026. https:\/\/doi.org\/10.1182\/blood.2019004118","journal-title":"Blood"},{"key":"3980_CR89","doi-asserted-by":"publisher","unstructured":"Shaw TI, Pounds S, Cao X, Ma J, Palacios G, Mason J, Perkins S, Wu G, Fan Y, Wang J, Zhou X, Obermayer A, Kinney MC, Kraveka J, Gross T, Sandlund J, Zhang J, Mullighan C, Lim MS, Leventaki V (2024) Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-4145750\/v1","DOI":"10.21203\/rs.3.rs-4145750\/v1"},{"key":"3980_CR90","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","volume":"111","author":"MC Le Deley","year":"2008","unstructured":"Le Deley MC, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, Zimmermann M, Brugieres L, Intergroup E, for Childhood Non-Hodgkin L, (2008) Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood 111:1560\u20131566. https:\/\/doi.org\/10.1182\/blood-2007-07-100958","journal-title":"Blood"},{"key":"3980_CR91","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood-2013-09-526202","volume":"123","author":"C Damm-Welk","year":"2014","unstructured":"Damm-Welk C, Mussolin L, Zimmermann M, Pillon M, Klapper W, Oschlies I, d\u2019Amore ES, Reiter A, Woessmann W, Rosolen A (2014) Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma. Blood 123:334\u2013337. https:\/\/doi.org\/10.1182\/blood-2013-09-526202","journal-title":"Blood"},{"key":"3980_CR92","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124:1473\u20131480. https:\/\/doi.org\/10.1182\/blood-2014-04-571091","journal-title":"Blood"},{"key":"3980_CR93","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/PAS.0000000000001941","volume":"46","author":"AL Feldman","year":"2022","unstructured":"Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S (2022) Immunohistochemical approach to genetic subtyping of anaplastic large cell lymphoma. Am J Surg Pathol 46:1490\u20131499. https:\/\/doi.org\/10.1097\/PAS.0000000000001941","journal-title":"Am J Surg Pathol"},{"key":"3980_CR94","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","volume":"482","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES (2023) New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch 482:227\u2013244. https:\/\/doi.org\/10.1007\/s00428-022-03414-4","journal-title":"Virchows Arch"},{"key":"3980_CR95","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.v98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98:280\u2013286. https:\/\/doi.org\/10.1182\/blood.v98.2.280","journal-title":"Blood"},{"key":"3980_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","volume":"159","author":"SD Dojcinov","year":"2023","unstructured":"Dojcinov SD, Quintanilla-Martinez L (2023) How I Diagnose EBV-positive B- and T-cell lymphoproliferative disorders. Am J Clin Pathol 159:14\u201333. https:\/\/doi.org\/10.1093\/ajcp\/aqac105","journal-title":"Am J Clin Pathol"},{"key":"3980_CR97","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443\u2013451","journal-title":"Blood"},{"key":"3980_CR98","first-page":"5738","volume":"7","author":"MC Smith","year":"2014","unstructured":"Smith MC, Cohen DN, Greig B, Yenamandra A, Vnencak-Jones C, Thompson MA, Kim AS (2014) The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. Int J Clin Exp Pathol 7:5738\u20135749","journal-title":"Int J Clin Exp Pathol"},{"key":"3980_CR99","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, Ito Y, Fukuhara N, Hirose A, Takeda Y, Makita M, Endo T, Kimura SI, Ishimura M, Miura O, Ohga S, Kimura H, Fujiwara S, Arai A (2020) Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv 4:2918\u20132926. https:\/\/doi.org\/10.1182\/bloodadvances.2020001451","journal-title":"Blood Adv"},{"key":"3980_CR100","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2018893750","volume":"133","author":"JI Cohen","year":"2019","unstructured":"Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, Bu W, Turk SP, Liepshutz K, Hornung RL, Fassihi H, Sarkany RP, Bonnycastle LL, Chines PS, Swift AJ, Myers TG, Levoska MA, DiGiovanna JJ, Collins FS, Kraemer KH, Pittaluga S, Jaffe ES (2019) Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites. Blood 133:2753\u20132764. https:\/\/doi.org\/10.1182\/blood.2018893750","journal-title":"Blood"},{"key":"3980_CR101","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jaad.2013.01.037","volume":"69","author":"M Sangueza","year":"2013","unstructured":"Sangueza M, Plaza JA (2013) Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases. J Am Acad Dermatol 69:112\u2013119. https:\/\/doi.org\/10.1016\/j.jaad.2013.01.037","journal-title":"J Am Acad Dermatol"},{"key":"3980_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/bjd.13411","volume":"172","author":"T Miyake","year":"2015","unstructured":"Miyake T, Yamamoto T, Hirai Y, Otsuka M, Hamada T, Tsuji K, Morizane S, Suzuki D, Aoyama Y, Iwatsuki K (2015) Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol 172:56\u201363. https:\/\/doi.org\/10.1111\/bjd.13411","journal-title":"Br J Dermatol"},{"key":"3980_CR103","doi-asserted-by":"publisher","unstructured":"Ruan Y, Shen X, Shi R, Zhao X, Zheng J (2020) Hydroa vacciniforme-like lymphoproliferative disorder treated with intravenous immunoglobulin: long-term remission without haematopoietic stem cell transplantation or chemotherapy. Acta Derm Venereol 100:adv00192. https:\/\/doi.org\/10.2340\/00015555-3556","DOI":"10.2340\/00015555-3556"},{"key":"3980_CR104","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","volume":"122","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Ridaura C, Nagl F, Saez-de-Ocariz M, Duran-McKinster C, Ruiz-Maldonado R, Alderete G, Grube P, Lome-Maldonado C, Bonzheim I, Fend F (2013) Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood 122:3101\u20133110. https:\/\/doi.org\/10.1182\/blood-2013-05-502203","journal-title":"Blood"},{"key":"3980_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00428-022-03427-z","volume":"482","author":"TA Tousseyn","year":"2023","unstructured":"Tousseyn TA, King RL, Fend F, Feldman AL, Brousset P, Jaffe ES (2023) Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities. Virchows Arch 482:207\u2013226. https:\/\/doi.org\/10.1007\/s00428-022-03427-z","journal-title":"Virchows Arch"},{"key":"3980_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.humpath.2017.08.015","volume":"68","author":"EM Moore","year":"2017","unstructured":"Moore EM, Swerdlow SH, Gibson SE (2017) J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Hum Pathol 68:47\u201353. https:\/\/doi.org\/10.1016\/j.humpath.2017.08.015","journal-title":"Hum Pathol"},{"key":"3980_CR107","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3389\/fonc.2019.00881","volume":"9","author":"E De Matteo","year":"2019","unstructured":"De Matteo E, Garcia Lombardi M, Preciado MV, Chabay P (2019) Changes in EBV association pattern in pediatric classic Hodgkin lymphoma from a single institution in Argentina. Front Oncol 9:881. https:\/\/doi.org\/10.3389\/fonc.2019.00881","journal-title":"Front Oncol"},{"key":"3980_CR108","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","volume":"4","author":"F Maura","year":"2023","unstructured":"Maura F, Ziccheddu B, Xiang JZ, Bhinder B, Rosiene J, Abascal F, Maclachlan KH, Eng KW, Uppal M, He F, Zhang W, Gao Q, Yellapantula VD, Trujillo-Alonso V, Park SI, Oberley MJ, Ruckdeschel E, Lim MS, Wertheim GB, Barth MJ, Horton TM, Derkach A, Kovach AE, Forlenza CJ, Zhang Y, Landgren O, Moskowitz CH, Cesarman E, Imielinski M, Elemento O, Roshal M, Giulino-Roth L (2023) Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells. Blood Cancer Discov 4:208\u2013227. https:\/\/doi.org\/10.1158\/2643-3230.BCD-22-0128","journal-title":"Blood Cancer Discov"},{"key":"3980_CR109","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346\u20131356. https:\/\/doi.org\/10.1097\/00000478-200310000-00007","journal-title":"Am J Surg Pathol"},{"key":"3980_CR110","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","volume":"38","author":"AR Huppmann","year":"2014","unstructured":"Huppmann AR, Nicolae A, Slack GW, Pittaluga S, Davies-Hill T, Ferry JA, Harris NL, Jaffe ES, Hasserjian RP (2014) EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol 38:316\u2013324. https:\/\/doi.org\/10.1097\/PAS.0000000000000107","journal-title":"Am J Surg Pathol"},{"key":"3980_CR111","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","volume":"2","author":"L Quintanilla-Martinez","year":"2009","unstructured":"Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y, Parrens M, Pileri S, Ott G (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux. France J Hematop 2:211\u2013236. https:\/\/doi.org\/10.1007\/s12308-009-0053-9","journal-title":"France J Hematop"},{"key":"3980_CR112","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","volume":"11","author":"L Thurner","year":"2020","unstructured":"Thurner L, Hartmann S, Fadle N, Regitz E, Kemele M, Kim YJ, Bohle RM, Nimmesgern A, von Muller L, Kempf VAJ, Weniger MA, Neumann F, Schneider N, Vornanen M, Sundstrom C, de Leval L, Engert A, Eichenauer DA, Kuppers R, Preuss KD, Hansmann ML, Pfreundschuh M (2020) Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun 11:2465. https:\/\/doi.org\/10.1038\/s41467-020-16375-6","journal-title":"Nat Commun"},{"key":"3980_CR113","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","volume":"30","author":"S Prakash","year":"2006","unstructured":"Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S (2006) IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 30:585\u2013592. https:\/\/doi.org\/10.1097\/01.pas.0000194741.87798.45","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03980-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:31:27Z","timestamp":1738200687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03980-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03980-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript is a review with no original results; therefore, no ethics approval is needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}